A case for regulatory freeze?

Market participants are naturally worried about the immediate costs of regulation, some of them still uncertain about the future benefits. But with all the twists and turns on the road to regulatory change, meeting the requirements imposed by regulators is no easy task. Whatever the legislation, the politicians agree on the broad principles and set a go-live date and then the clock starts ticking to agree the finer details and deliver the software. But the approach that has typically... Read More

Putting MiFID II into practice

As firms march headlong towards 2018 the detailed implementation of MiFID II is well and truly underway. Even in the equities camp where MiFID II, remember, is an intended adjustment to existing rules, the practicalities of trade and transaction reporting mechanics are evolving. Whether ESMA ever envisaged such a complex campaign is debatable, but early advocates of splitting MiFID II up into more manageable chunks may not have been far off the mark. Sticking with minimum mandatory... Read More

Sometimes it’s tough being average

Back in March the CME Group postponed the effective date of amendments to Rule 553 (“Average Price System”) until July 2, 2018 to allow sufficient time for affected Exchange Clearing Member Firms and CME Clearing to make the necessary changes to implement the rule. CME Rule 553 permits a clearing member firm to calculate an average price for trades via its own internally developed average pricing system, rather than requiring the use of CME’s Average Pricing... Read More

Copyright © 2018 Fidessa Group Holdings Limited. All rights reserved.

The information contained within this website is provided for informational purposes only. Fidessa will use reasonable care to ensure that information is accurate at the time it is made available, and for the duration that it remains on the site. The information may be changed by Fidessa at any time without notice. We also reserve the right to close the website at any time. No representation or warranty, expressed or implied, is given on behalf of Fidessa or any of its respective directors, employees, agents, or advisers as to the accuracy or completeness of the information or opinions contained herein or its suitability for any purpose and, save in the case of fraud, all liability for direct, indirect, special, consequential or other loss or damages of whatever kind that may arise from use of the website is hereby excluded to the fullest extent permitted by law. Any decisions you make based on the information in this website are your sole responsibility and information on the website should not be relied upon in connection with any investment decision.

The copyright of this website belongs to Fidessa. All other intellectual property rights are reserved.

Reproduction or redistribution of this information is prohibited except with written permission from Fidessa.